Summary & Overview
HCPCS Q4141: Alloskin ac, Per Square Centimeter (Skin Substitute)
HCPCS Level II code Q4141 represents Alloskin ac, billed per square centimeter as an add-on item in conjunction with a primary procedure. This code is used when a biologic skin substitute is applied for wound coverage, burn care, or reconstructive procedures and is important nationally because it standardizes reporting and facilitates reimbursement for an increasingly used class of advanced wound products. Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of clinical context for Q4141, typical sites of service, and the role of add-on product codes in billing workflows. The publication covers benchmark considerations across major national payers, coding and billing practice implications for procedural settings, and where to find policy updates or coverage guidance. It also highlights common modifiers associated with procedure add-ons and notes when to bill per square centimeter versus per unit. Data not available in the input is identified where applicable. The content is intended to inform coding accuracy, billing consistency, and payer engagement for providers and revenue cycle professionals handling biologic skin substitute products.
Billing Code Overview
HCPCS Level II code Q4141 designates Alloskin ac, per square centimeter as an add-on product billed in addition to a primary procedure. The code describes a biologic skin substitute product measured and reported by square centimeter, used to cover or treat areas requiring skin replacement or wound coverage.
Service type: Biologic skin substitute application / graft coverage
Typical site of service: Operating room, procedure room, burn center, or specialized wound care clinic
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a large, full-thickness or complex partial-thickness skin loss following burn injury, traumatic avulsion, or excision of necrotic tissue who requires biologic dermal substitute coverage. In a hospital operating room or ambulatory surgical center, the patient undergoes debridement or excision of nonviable tissue under general or regional anesthesia. After achieving hemostasis and preparing the wound bed, the surgeon applies an allogeneic cultured skin product, billed as Q4141 per square centimeter, as an adjunctive graft material to promote dermal regeneration prior to definitive autografting or to serve as definitive coverage when autograft is limited. Typical workflow steps: preoperative wound assessment and photography, operative debridement/excision, measurement of treated surface area documented in square centimeters, application of Q4141 product with appropriate fixation and dressing, and post-procedure wound care visits for graft take assessment and dressing changes. Usual sites of service are the inpatient surgical suite, outpatient hospital operating room, or ambulatory surgery center; select appropriate anesthesia and facility coding in addition to the Q4141 add-on code.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |